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Lack of Association between Chlamydia trachomatis Infection and Cervical Cancer -Taq Man Realtime PCR Assay Findings
Taghi Naserpour Farivar*, Pouran Johari facilitate human papilloma virus infection or may interfere immune response and viral clearance and by this way support persistence infection of HPV (Steben et al., 2007) . C. trachomatis belongs to Chlamydia genus, which includes obligatory intracellular pathogens. Chlamydiae are small, gram-negative bacteria and are characterized by a small genome with a limited capacity of biosynthesis. This bacterium causes several human diseases, including neonatal pneumonia, urethritis/cervicitis, trachoma and conjunctivitis (Saveleva et al., 2010) . Epidemiological studies have shown that there is a relationship among cervical cancer associated with C. trachomatis antibodies, HPV type and HPV co-factors (Madeleine et al., 2007) .
On the other hand, there are many studies in which the researcher did not find any association between contamination and infection with C. trachomatis and HSV cervical cancer (Paavonen et al., 2003; Naucler et al., 2007; Farivar et al., 2012) .
As traditional PCR used in previous studies has a poor precision, low sensitivity, short dynamic range and low resolution in comparison with Real-time PCR (Naserpour et al., 2012) , in this survey we used the latter sensitive and quantitative assay in evaluation of C. trachomatis prevalence in formaldehyde fixed paraffin embedded pathologic blocks of cervical cancer patients and control individuals.
Materials and Methods
All the process on the patients samples were confirmed by Qazvin University of Medical Sciences Ethics Committee and patients were signed related forms.
Seventy-six formaldehyde fixed paraffin embedded tissue specimens from patients with pathologically proved history of cervical cancer referred to oncology departments at university hospitals, including Kosar hospital in Qazvin and Shohada Hospital, Imam Hossein Hospital and Mahdyeh Hospital of Shahid Beheshti University of Medical Sciences in Tehran were included to the study. Also, 150 blocks from healthy peoples referring to Qazvin University Hospitals for hysterectomy with different gynecological diseases other than cervical cancer were selected as control group.
Two hundred milligrams of tissues within the blocks were collected by 5 micrometer slices in a 1.5 ml Eppendorf microtube and after initial deparaffinization by Xylol and Ethanol , their DNA were extracted using Roche High Pure Nucleic Acid Extraction kit (Roche, IRAN). Taq Man real-timePCR assay was done by C. trachomatis Primer Design kit (Primer Design, UK). Each Taq Man real-time PCR reaction consists of l0 μl of ABI 2X Master mix, 1μl of HSV-2 probe/primer mixture, 1μl of internal extraction control, 3 μl of RNase/DNase free DDW (provided in the kit) and 5 μl of extracted DNA or standard (provided in the kit).
Endogenous Beta-actin gene (ACTB) control which was used for qualifying biological samples amplified by a mixture of 10 μl of Master mix, 1 μl of ACTB probe/ primer, 4 μl of DNase/RNase free DDW and 5 μl of patient or control extracted DNA samples. PCR program as recommended by manufacturer was as follows: 10 minutes in 95 ο C followed by 50 cycles of 95 ο C for 10 seconds and 60 ο C for 60 second and fluorescent accusation was done at the latter stage.
Statistical analysis
Data were analysed using SPSS software,version 17.0. The strength of the linear relationship between logarithms of mean number of bacteria and Ct values for probes were measured using the Pearson correlation coefficient.
Results
We did not find any positive C. trachomatis DNA in our patients but found three positive specimens among our control group.
The lowest and highest age range in patients and control groups were 21 and 78, 22 and 76 years, respectively. In this study our real-time PCR efficiency, regression coefficient and r2 were, 99.594%, 0.998, 35.432 respectively (Figure 1 ) and we could not find any C. trachomatis DNA in samples of our patients although in contrast there were 3 positive samples among our controls (Figure 2) .
Our date showed that in our studied population there was no relationship between C. trachomatis infection and the types of cervical cancer ie. squamous cell carcinoma or adenocarcinoma (data were not shown).
Discussion
Studying the role of C. trachomatis in stimulating cervical cancer is one of the most interesting areas in bio-oncology researches. On the other hand, Taq Man real-time PCR in addition to offering more sensitivity and specificity than those of traditional PCR, provides us with the possibility of continuous studying of PCR products and hence, it is a favorable test in detection of C. trachomatis prevalence in cervical cancer.
In this study, our findings showed no specimens with C. trachomatis infection in patients and we found three positive specimens among our control group.There are numerous studies which confirm our results.
Quint et al. in their study on 71 cervical adenocarcinoma biopsy by PCR assays, reported that none of their cases were positive for C. trachomatis (Quint et al., 2009 ). Naucler et al. in a nested case control study on 13595 Taiwanese women by serologic assay, found that in their studied individuals C. trachomatis was not associated with cervical cancer (Naucler et al., 2007) . Paavonen in a case-control study on serum banks found that there was no materially difference interaction among HPV16 DNA-positive squamous cell carcinomas and there was an antagonism in the carcinogenic effects of C. trachomatis and HPV6/11 with HPV16 (Paavonen et al., 2003) . Safaeian and colleagues in their study on 182 women with prevalent and 132 women with incident histological cervical neoplasia, reported that by assessing DNA or IgG and after controlling for carcinogenic HPV-positive status, there was not any association between C. trachomatis status and risk of cervical premalignancy (Safaeian et al., 2010). Zereu and colleagues in their study on 206 paraffin-embedded cases of adenocarcinoma of the uterine cervix by PCR assay found that all samples were negative for HSV-2 DNA and C. trachomatis DNA (Zereu et al., 2007) . Castle and colleague reported that they were unable to find any association between severity of HTLV-I, C. trachomatis and/or HSV_2 in Jamaican women with cervical neoplasia (Castle et al., 2003) . All these studies like ours, confirm that there is no association between existence of C. trachomatis DNA and cervical cancer.
On the other hand, Wallin and colleagues in their study on 118 women who after having a normal Pap smear had a cervical cancer diagnosis, showed that a prior cervical C. trachomatis infection was associated with an increased risk for development of invasive cervical cancer (Wallin et al., 2002) .
Samoff and her colleagues reported that the association between Chlamydia infection and cervical cancer may be due to an effect of Chlamydia infection on persistence of high-risk HPV (Samoff et al., 2005) . Deluca and colleague in a study on 189 sexually active women, with cytological abnormalities in cervical epithelium by PCR technique, found that women infected with C. trachomatis showed a higher risk for viral infection than non-infected ones (Finan et al., 2006) . Also, Finan and colleagues in their study on 86 HPV-positive and 213 HPV-negative women by PCR assay, found that a higher prevalence of C. trachomatis was found in HPV-positive samples (Finan et al., 2006) .
Bosch and de Sanjose in their study on the epidemiology of human papilloma virus infection and cervical cancer found that previous exposure to other sexually transmitted diseases such as C. trachomatis and Herpes Simplex Virus type 2 (Bosch et al., 2007) was a risk factor for cervical cancer in their studied patients and Madeleine and colleague in their study in a population-based study reported that the risk of squamous cell carcinomas associated with antibodies to C. trachomatis will be increased. Also they reported an association between specific serotypes of C. trachomatis and squamous cell carcinomas.
Du and colleagues in a study on about 20,000 cervical cancer deaths, found that there was a high Chlamydia infection rate and association between C. trachomatis and the cervical cancer mortality rate (Du et al., 2010) . Dalstrom and colleagues reported that previous exposure to C. trachomatis had a strongly increased risk for cervical cancer (Dahlstrom et al., 2011) . Also, Valadan in a case-control study reported that serum antibodies to C. trachomatis were associated with an increased risk for Cervical intraepithelial neoplasia (CIN).
There was also a significant association between presence of inclusion bodies for C. trachomatis and CIN. These results indicate a strong association between CIN and Chlamydia cervicitis (Valadan et al., 2010) .
Clearly these studies do not confirm our results. The differences between obtained results in these studies may lay back in the selected evaluating assay. While molecular methods evaluate present infection with C. trachomatis, seroepidemiological techniques evaluate previous encountering with this micro-organism. Finally, it seems that there is some significant methodological issues, which cloud interpretation of the results in some previous studies regarding the role of C. trachomatis in cervical cancer (Miller et al., 2011) .
Using Taq Man real-time PCR assay which has high sensitivity and specificity with capacity of determining two hundred copies of viral genome per micro liter of sample provide us a very good reliability for assessing our obtained results.
With respect to the absence of any positive C. trachomatis DNA in our patients and also the presence of three positive specimens among our controls specimens, it seems that based on results obtained from the specimens examined in the present study we did not find any association between the presence of C. trachomatis DNA and cervical cancer.
